Nothing Special   »   [go: up one dir, main page]
News & Perspective
Drugs & Diseases
CME & Education
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Friday, November 15, 2024
      News & Perspective Drugs & Diseases CME & Education Video Decision Point

      From Medscape Nephrology

      Coverage from the

      Kidney Week 2024: American Society of Nephrology Annual Meeting

      October 23 - 27, 2024; San Diego, California

      October 23 - 27, 2024 San Diego, California

      Conference News

      Medscape Nephrology© 

      Popular News From Kidney Week 2023

      • Albuminuria Reduction Fuels Finerenone's Kidney Benefits Albuminuria Reduction Fuels Finerenone's Kidney Benefits The findings of the mediation analyses underscore the important role that albuminuria plays in the nephropathy and related comorbidities associated with type 2 diabetes and CKD.
        Medscape Medical News, Nov 17, 2023
      • Risk Calculator for Early-Stage CKD May Soon Enter US Market Risk Calculator for Early-Stage CKD May Soon Enter US Market For adults with early-stage chronic kidney disease (CKD), a proprietary formula performed well in stratifying risk of progression to more severe kidney dysfunction and of increased healthcare needs.
        Medscape Medical News, Nov 10, 2023
      • Aprocitentan Reduces Resistant Hypertension in CKD Aprocitentan Reduces Resistant Hypertension in CKD The findings provide support for potentially using aprocitentan in patients with BP that remains elevated despite treatment with three established antihypertensive drug classes and with stage 3 CKD.
        Medscape Medical News, Nov 07, 2023

      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Manage Preferences Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      Editions
      English Deutsch Español Français Português
      All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC. This website also contains material copyrighted by 3rd parties.